Stockscreener 앱 받기
1.69%
Pfizer Inc 주식(PFE)의 최신 뉴스
Pfizer to acquire obesity drugmaker - Taipei Times
Metsera, Inc. Shares Dive Amid Pfizer Acquisition - TipRanks
Pfizer Clinches $10 Billion Metsera Deal as Novo Nordisk Loses Weight-Loss Drug Battle - TipRanks
Pfizer, Metsera Enter Merger Agreement as Danish Rival Novo Nordisk Bows Out - MarketScreener
Key facts: Pfizer to acquire Metsera for over $10B; Novo Nordisk stands firm - TradingView
Pfizer wins $10 billion bidding war for obesity drug developer - New York Post
Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer - MSN
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk - Yahoo Finance
Pfizer wins bidding war for Metsera with $10B offer - BioPharma Dive
Pfizer acquires Metsera for $10 billion and targets the obesity drug market - MarketScreener
Pfizer clinches $10 billion Metsera deal, outbidding Novo Nordisk - TradingView
Pfizer To Buy Metsera In Deal Valued Up To $10 Billion - Pulse 2.0
2 No-Brainer Dividend Stocks to Buy With $100 in November - The Motley Fool
Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition - Fox Business
Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits - Yahoo Finance
Pfizer and Metsera Reach Deal Expected to Top $10 Billion - The Wall Street Journal
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal - The New York Times
Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal - Seeking Alpha
Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer - Seeking Alpha
Pfizer Wins Metsera Bidding War Over Novo With Final $10B Price Tag - BioSpace
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo - MSN
Pfizer to Acquire Metsera in $10 Billion Weight-Loss Drug Deal, Surpassing Novo Nordisk - Analytics Insight
Pfizer to Buy Metsera for $10 Billion, Capping Bidding War - Bloomberg.com
Metsera to accept Pfizer after call from US antitrust regulators - MLex
Pfizer seals $10bn deal for Metsera as Novo Nordisk exits race - Nikkei Asia
Pfizer Prevails in Obesity Biotech Battle, Secures Metsera Over Novo Nordisk - FXLeaders
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance - Benzinga
Pfizer acquires Metsera in $10 billion deal after competitive bidding with Novo Nordisk - MSN
Pfizer Wins! Acquires Metsera for $10 Billion, Outbidding Novo-Nordisk A/S - 富途牛牛
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports - 1470 & 100.3 WMBD
Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle - The Economic Times
Metsera says Pfizer to buy Metsera for up to $86.25 per share - MarketScreener
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer - MarketScreener
Pfizer sweetens offer for Metsera in bidding war against Novo - The Edge Malaysia
Metsera enters merger agreement with Pfizer - TradingView
Pfizer sweetens its offer for Metsera in bidding war against NovoBloomberg news - MarketScreener
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits - MarketScreener
Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech - Law360
Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race - Healthcare Brew
Pfizer, Novo risk overpaying in Metsera chase - Axios
Metsera's complex choice between Novo and Pfizer - Axios
“Pfizer (PFE) Beat The Numbers And People Just Yawned,” Says Jim Cramer - MSN
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call - Zacks Investment Research
Novo CEO Fires Back at Pfizer From White House: ‘Put Your Hand in Your Pocket’ - BioSpace
Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings” - Insider Monkey
Novo Nordisk Sweetens Bid for Obesity Drug Startup Metsera - Bloomberg.com
Pfizer Matches Novo's $10B Metsera Bid, And Other Rumors - Law360
Jim Cramer Highlights the Woes of Pfizer and the Drug Sector - Insider Monkey
Novo Nordisk CEO Challenges Pfizer to Raise its Bid for Metsera - Bloomberg.com
Novo CEO says its bid for Metsera is higher - Reuters
3.70%
0.34%
자본화:
|
볼륨(24시간):